Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

311 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Liver Stiffness Hinders Normalization of Systemic Inflammation and Endothelial Activation after Hepatitis C Virus (HCV) Eradication in HIV/HCV Coinfected Patients.
Álvarez B, Restrepo C, García M, Navarrete-Muñoz MA, Jiménez-Sousa MA, Prieto L, Cabello A, Nistal S, Resino S, Górgolas M, Rallón N, Benito JM. Álvarez B, et al. Among authors: resino s. Vaccines (Basel). 2020 Jun 19;8(2):323. doi: 10.3390/vaccines8020323. Vaccines (Basel). 2020. PMID: 32575428 Free PMC article.
Increased Th1, Th17 and pro-fibrotic responses in hepatitis C-infected patients are down-regulated after 12 weeks of treatment with pegylated interferon plus ribavirin.
Jimenez-Sousa MA, Almansa R, de la Fuente C, Caro-Paton A, Ruiz L, Sanchez-Antolín G, Gonzalez JM, Aller R, Alcaide N, Largo P, Resino S, de Lejarazu RO, Bermejo-Martin JF. Jimenez-Sousa MA, et al. Among authors: resino s. Eur Cytokine Netw. 2010 Jun;21(2):84-91. doi: 10.1684/ecn.2010.0191. Epub 2010 May 19. Eur Cytokine Netw. 2010. PMID: 20483710 Free article.
Modeling the probability of sustained virological response to therapy with pegylated interferon plus ribavirin in patients coinfected with hepatitis C virus and HIV.
Medrano J, Neukam K, Rallón N, Rivero A, Resino S, Naggie S, Caruz A, Calvino A, Macías J, Benito JM, Sánchez-Piedra C, Vispo E, Barreiro P, McHutchison J, Pineda JA, Soriano V. Medrano J, et al. Among authors: resino s. Clin Infect Dis. 2010 Nov 15;51(10):1209-16. doi: 10.1086/656811. Clin Infect Dis. 2010. PMID: 20964522
Soluble markers of inflammation are associated with Framingham scores in HIV-infected patients on suppressive antiretroviral therapy.
Guzmán-Fulgencio M, Medrano J, Rallón N, Echeverria-Urabayen A, Miguel Benito J, Restrepo C, García-Álvarez M, Vispo E, San Roman J, Sánchez-Piedra C, Soriano V, Resino S. Guzmán-Fulgencio M, et al. Among authors: resino s. J Infect. 2011 Nov;63(5):382-90. doi: 10.1016/j.jinf.2011.08.006. Epub 2011 Aug 12. J Infect. 2011. PMID: 21855573
Bacterial DNA translocation and liver disease severity among HIV-infected patients with chronic hepatitis C.
García-Álvarez M, Berenguer J, Guzman-Fulgencio M, Alvarez E, Cosín J, Micheloud D, Jimenez-Sousa MA, Fernández-Rodríguez A, Aldámiz-Echevarría T, Carrero A, Miralles P, Resino S. García-Álvarez M, et al. Among authors: resino s. J Acquir Immune Defic Syndr. 2012 Dec 15;61(5):552-6. doi: 10.1097/QAI.0b013e31826ea109. J Acquir Immune Defic Syndr. 2012. PMID: 22932319
IL28B polymorphisms are associated with severity of liver disease in human immunodeficiency virus (HIV) patients coinfected with hepatitis C virus.
Guzmán-Fulgencio M, Berenguer J, García-Álvarez M, Fernández-Rodríguez A, Jiménez-Sousa MA, Alvarez E, Micheloud D, López JC, Miralles P, Cosín J, Catalán P, Resino S. Guzmán-Fulgencio M, et al. Among authors: resino s. J Infect. 2013 Feb;66(2):170-8. doi: 10.1016/j.jinf.2012.10.025. Epub 2012 Oct 26. J Infect. 2013. PMID: 23103287
311 results